Hosted on MSN
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
Novo Nordisk is partnering with OpenAI to "bring new and better treatment options to patients faster," the Danish drugmaker said Tuesday. "Integrating AI in our everyday work gives us the ability to ...
Hosted on MSN
Novo Nordisk joins forces with OpenAI to fast-track drug research
Novo Nordisk's partnership with OpenAI will “help the company bring new and better treatment options to patients faster,” the Danish pharmaceutical company announced on Tuesday. The collaboration will ...
techtimes
GPT-Rosalind Drug Discovery Update: OpenAI Cuts Genomics Compute, Expands Global Access
OpenAI published a substantial update to GPT-Rosalind on June 3, 2026, deepening the domain-specialized model's performance across drug discovery, genomics, and wet-lab research — and opening the ...
techtimes
OpenAI’s Rosalind Biodefense Opens GPT-Rosalind to Vetted Partners：Dual-Use Fears Mount
OpenAI announced Rosalind Biodefense on May 29, 2026, framing it as "defensive acceleration": steering frontier AI toward the institutions that prevent, detect, and respond to biological threats. The ...